facebook
twitter
Login
Register
Medical Dialogues
Speciality Dialogues
Education Dialogues
Medical Jobs
Medical Matrimony
MD Brand Connect
News
Financial Results
Hospitals & Diagnostics
IT / Health Venture
Implants / Devices
Insurance
Key Movement
Pharmaceuticals
Policy
Technology
pharma-news
blog
Login
Register
Select Your Interest
Medical Dialogues
Speciality Dialogues
Education Dialogues
Medical Jobs
Medical Matrimony
Login
Register
Home
News
Financial Results
Hospitals & Diagnostics
IT / Health Venture
Implants / Devices
Insurance
Key Movement
Pharmaceuticals
Policy
Technology
pharma-news
blog
Home
News
Fortis Q2 net loss widens to Rs 142 Crore; IHH transaction to be completed shortly
Strides' subsidiary inks pact with SUDA Pharmaceuticals for migraine drug
Novartis division Sandoz recalls one lot of Losartan drug
Fortis Healthcare CEO Bhavdeep Singh quits
Glenmark ties up with South Korea's SCD for ophthalmic products
Lilly to consider more acquisitions like Rs 115 Crore Armo buy
AstraZeneca sells older asthma, rhinitis drugs for $350 mln
NPPA fixes ceiling price of Nitrous Oxide, Oxygen, Details
NBCC inks pact with Health Ministry to buy out HSCC
Suven Life Sciences gets Product Patents in Israel and Japan
Foamix's treatment for common skin condition meets late-stage trial goals
Unichem acquires 20 percent stake in Optimus group for Rs 120 Crore
Prev
Next
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our
Cookie Policy
and
Cookie Settings.
Ok